A detailed history of Choreo, LLC transactions in Organon & Co. stock. As of the latest transaction made, Choreo, LLC holds 14,486 shares of OGN stock, worth $109,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,486
Previous 13,638 6.22%
Holding current value
$109,079
Previous $132,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$8.4 - $10.85 $7,123 - $9,200
848 Added 6.22%
14,486 $154,000
Q2 2025

Aug 12, 2025

SELL
$8.04 - $14.72 $82,546 - $151,130
-10,267 Reduced 42.95%
13,638 $132,000
Q1 2025

May 06, 2025

BUY
$14.29 - $16.41 $41,683 - $47,867
2,917 Added 13.9%
23,905 $355,000
Q4 2024

Jan 27, 2025

SELL
$14.44 - $18.83 $170,103 - $221,817
-11,780 Reduced 35.95%
20,988 $313,000
Q3 2024

Nov 07, 2024

BUY
$18.65 - $23.03 $96,886 - $119,640
5,195 Added 18.84%
32,768 $626,000
Q2 2024

Aug 06, 2024

BUY
$17.45 - $21.96 $481,148 - $605,503
27,573 New
27,573 $570,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Choreo, LLC Portfolio

Follow Choreo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.